HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$0.88
Day range
$0.85 - $1.04
Year range
$0.49 - $1.93
Market cap
44.22M USD
Avg Volume
365.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.26M | — |
Operating expense | 17.07M | -1.70% |
Net income | -14.02M | 16.29% |
Net profit margin | -619.53 | — |
Earnings per share | -0.22 | 63.68% |
EBITDA | -14.42M | 14.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.26M | 2.49% |
Total assets | 74.66M | -4.09% |
Total liabilities | 53.68M | 111.82% |
Total equity | 20.97M | — |
Shares outstanding | 43.96M | — |
Price to book | 1.84 | — |
Return on assets | -44.99% | — |
Return on capital | -103.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.02M | 16.29% |
Cash from operations | -13.67M | -2.27% |
Cash from investing | -9.00K | — |
Cash from financing | -3.00K | 99.87% |
Net change in cash | -13.68M | 12.31% |
Free cash flow | -6.94M | 6.03% |
About
Founded
2016
Headquarters
Website
Employees
56
